The Patient Symptom Experience After Tisagenlecleucel and Lisocabtagene Maraleucel CAR T-Cell Therapy for Lymphoma. - Andersen L; Baker KM; Difilippo H; Meghani SH; Porter D; Deng J (Seminars in oncology nursing, 2024)